726 related articles for article (PubMed ID: 20971133)
1. Motor neuron trophic factors: therapeutic use in ALS?
Gould TW; Oppenheim RW
Brain Res Rev; 2011 Jun; 67(1-2):1-39. PubMed ID: 20971133
[TBL] [Abstract][Full Text] [Related]
2. MicroNeurotrophins Improve Survival in Motor Neuron-Astrocyte Co-Cultures but Do Not Improve Disease Phenotypes in a Mutant SOD1 Mouse Model of Amyotrophic Lateral Sclerosis.
Glajch KE; Ferraiuolo L; Mueller KA; Stopford MJ; Prabhkar V; Gravanis A; Shaw PJ; Sadri-Vakili G
PLoS One; 2016; 11(10):e0164103. PubMed ID: 27716798
[TBL] [Abstract][Full Text] [Related]
3. The function of neurotrophic factor receptors expressed by the developing adductor motor pool in vivo.
Gould TW; Oppenheim RW
J Neurosci; 2004 May; 24(19):4668-82. PubMed ID: 15140938
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor prevents G93A-SOD1-induced motor neuron degeneration.
Lunn JS; Sakowski SA; Kim B; Rosenberg AA; Feldman EL
Dev Neurobiol; 2009 Nov; 69(13):871-84. PubMed ID: 19672955
[TBL] [Abstract][Full Text] [Related]
5. Sporadic amyotrophic lateral sclerosis: is SMN-Gemins protein complex of importance for the relative resistance of oculomotor nucleus motoneurons to degeneration?
Sulejczak D; Chrapusta SJ; Dziewulska D; Rafałowska J
Folia Neuropathol; 2018; 56(4):308-320. PubMed ID: 30786668
[TBL] [Abstract][Full Text] [Related]
6. A microfluidic approach to rescue ALS motor neuron degeneration using rapamycin.
Chennampally P; Sayed-Zahid A; Soundararajan P; Sharp J; Cox GA; Collins SD; Smith RL
Sci Rep; 2021 Sep; 11(1):18168. PubMed ID: 34518579
[TBL] [Abstract][Full Text] [Related]
7. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotection in amyotrophic lateral sclerosis: from pathology to treatment.
Murri L
CNS Neurol Disord Drug Targets; 2010 Jul; 9(3):258. PubMed ID: 20406186
[No Abstract] [Full Text] [Related]
9. Quantifying motor neuron loss in ALS.
Narasimhan K
Nat Neurosci; 2006 Mar; 9(3):304. PubMed ID: 16498424
[No Abstract] [Full Text] [Related]
10. Myelin degeneration induced by mutant superoxide dismutase 1 accumulation promotes amyotrophic lateral sclerosis.
Kim S; Chung AY; Na JE; Lee SJ; Jeong SH; Kim E; Sun W; Rhyu IJ; Park HC
Glia; 2019 Oct; 67(10):1910-1921. PubMed ID: 31290185
[TBL] [Abstract][Full Text] [Related]
11. Experimental rationale for the therapeutic use of neurotrophins in amyotrophic lateral sclerosis.
Seeburger JL; Springer JE
Exp Neurol; 1993 Nov; 124(1):64-72. PubMed ID: 8282083
[TBL] [Abstract][Full Text] [Related]
12. Interfering with lysophosphatidic acid receptor edg2/lpa
Gento-Caro Á; Vilches-Herrando E; García-Morales V; Portillo F; Rodríguez-Bey G; González-Forero D; Moreno-López B
Neuropathol Appl Neurobiol; 2021 Dec; 47(7):1004-1018. PubMed ID: 33508894
[TBL] [Abstract][Full Text] [Related]
13. Coactivation of GSK3β and IGF-1 Attenuates Amyotrophic Lateral Sclerosis Nerve Fiber Cytopathies in SOD1 Mutant Patient-Derived Motor Neurons.
Ting HC; Yang HI; Harn HJ; Chiu IM; Su HL; Li X; Chen MF; Ho TJ; Liu CA; Tsai YJ; Chiou TW; Lin SZ; Chang CY
Cells; 2021 Oct; 10(10):. PubMed ID: 34685754
[TBL] [Abstract][Full Text] [Related]
14. Analysis of neurotrophic factors in limb and extraocular muscles of mouse model of amyotrophic lateral sclerosis.
Harandi VM; Lindquist S; Kolan SS; Brännström T; Liu JX
PLoS One; 2014; 9(10):e109833. PubMed ID: 25334047
[TBL] [Abstract][Full Text] [Related]
15. Motoneuron cell death and neurotrophic factors: basic models for development of new therapeutic strategies in ALS.
Beck M; Karch C; Wiese S; Sendtner M
Amyotroph Lateral Scler Other Motor Neuron Disord; 2001 Mar; 2 Suppl 1():S55-68. PubMed ID: 11465926
[TBL] [Abstract][Full Text] [Related]
16. Aberrant regulation of DNA methylation in amyotrophic lateral sclerosis: a new target of disease mechanisms.
Martin LJ; Wong M
Neurotherapeutics; 2013 Oct; 10(4):722-33. PubMed ID: 23900692
[TBL] [Abstract][Full Text] [Related]
17. Empty mesoporous silica particles significantly delay disease progression and extend survival in a mouse model of ALS.
Leyton-Jaimes MF; Ivert P; Hoeber J; Han Y; Feiler A; Zhou C; Pankratova S; Shoshan-Barmatz V; Israelson A; Kozlova EN
Sci Rep; 2020 Nov; 10(1):20675. PubMed ID: 33244084
[TBL] [Abstract][Full Text] [Related]
18. Survival and death of mature avian motoneurons in organotypic slice culture: trophic requirements for survival and different types of degeneration.
Brunet N; Tarabal O; Portero-Otín M; Oppenheim RW; Esquerda JE; Calderó J
J Comp Neurol; 2007 Apr; 501(5):669-90. PubMed ID: 17299760
[TBL] [Abstract][Full Text] [Related]
19. Malonate-induced cortico-motoneuron death is attenuated by NT-4, but not by BDNF or NT-3.
Van Westerlaak MG; Bär PR; Cools AR; Joosten EA
Neuroreport; 2001 May; 12(7):1355-8. PubMed ID: 11388410
[TBL] [Abstract][Full Text] [Related]
20. Motor neuron intrinsic and extrinsic mechanisms contribute to the pathogenesis of FUS-associated amyotrophic lateral sclerosis.
Scekic-Zahirovic J; Oussini HE; Mersmann S; Drenner K; Wagner M; Sun Y; Allmeroth K; Dieterlé S; Sinniger J; Dirrig-Grosch S; René F; Dormann D; Haass C; Ludolph AC; Lagier-Tourenne C; Storkebaum E; Dupuis L
Acta Neuropathol; 2017 Jun; 133(6):887-906. PubMed ID: 28243725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
